Global Healthcare Parnters

Represented Global Healthcare Partners, a healthcare industry and private equity investment group, in its acquisition of a controlling interest in MPD Chemicals, a leading manufacturer of specialty chemicals primarily used in medical devices, industrial materials and pharmaceuticals, with three distinct manufacturing units: Monomer-Polymer and Dajac Labs, Silar Laboratories, and IsoSciences.